Ropes & Gray represented Apollo Therapeutics in the transaction. Apollo Therapeutics Group Limited (“Apollo”) and Sunshine Lake Pharma Co., Ltd. have entered into an exclusive license...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Apollo Therapeutics on its series C funding round. Apollo Therapeutics Limited, a biopharmaceutical company headquartered in Cambridge, has successfully raised $226.5 million in...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Apollo Therapeutics, while Kirkland & Ellis advised Patient Square Capital on the deal. Led by Patient Square Capital, and with participation from additional...
You must be a Standard 1 Year member to access this content.
